Phenomix – Medical Alley Association

Phenomix

Health2047 Spins Out Obesity Testing Company Phenomix Sciences

MENLO PARK, Calif.–(BUSINESS WIRE)–Health2047 Inc., the Silicon Valley-based innovation subsidiary of the American Medical Association (AMA), today announced the spin out of Phenomix Sciences (Phenomix), a phenotype testing company whose AI-derived test analyzes genomics, metabolomics and hormone levels to deliver a new personalized measure for obesity that enhances treatment outcomes. Phenomix provides a solution that […]

In the Know: Healthcare Stories from Medical Alley — January 7, 2019

U of M start-up CoreBiome acquired by OraSure Technologies, Inc POPS! Diabetes Care Inc. Raises New Financing Round for Launch of POPS! one System 3M to buy M*Modal healthcare software firm for $1 billion Latest Boston Sci Deal Shakes up Mitral Repair Market Catalyzing economic growth in the Heartland starts with research universities Health insurance […]

In The Know: December 6, 2018

Nearly 150 groups join AdvaMed’s anti medtech tax letter Inspire Medical offers another 1.5 million shares following April IPO   POPS! Diabetes Care Announces FDA Clearance of Their POPS!® one System   NxThera spinout NxPhase lands $10m for vapor ablation tech   Mayo Clinic Startup Phenomix Sciences Initiates $1M Seed Funding Round   IPM Earns […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER